_version_ 1784789319388495872
author Molinier, O.
Falchero, L.
Monnet, I.
Decroisette, C.
Neidhart, A-C.
Redureau, E.
Chiappa, A-M.
Bigot, F.
Bedossa, A.
Amrane, K.
Jeandeau, S.
Dujon, C.
Bugnet, A-S.
Bonnefoy, P.
Alizon, C.
Meyer, N.
Couraud, S.
Cortot, A.
Letierce, A.
Debieuvre, D.
author_facet Molinier, O.
Falchero, L.
Monnet, I.
Decroisette, C.
Neidhart, A-C.
Redureau, E.
Chiappa, A-M.
Bigot, F.
Bedossa, A.
Amrane, K.
Jeandeau, S.
Dujon, C.
Bugnet, A-S.
Bonnefoy, P.
Alizon, C.
Meyer, N.
Couraud, S.
Cortot, A.
Letierce, A.
Debieuvre, D.
author_sort Molinier, O.
collection PubMed
description
format Online
Article
Text
id pubmed-9472519
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-94725192022-09-14 509P COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study Molinier, O. Falchero, L. Monnet, I. Decroisette, C. Neidhart, A-C. Redureau, E. Chiappa, A-M. Bigot, F. Bedossa, A. Amrane, K. Jeandeau, S. Dujon, C. Bugnet, A-S. Bonnefoy, P. Alizon, C. Meyer, N. Couraud, S. Cortot, A. Letierce, A. Debieuvre, D. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-09 2022-09-13 /pmc/articles/PMC9472519/ http://dx.doi.org/10.1016/j.annonc.2022.07.637 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Molinier, O.
Falchero, L.
Monnet, I.
Decroisette, C.
Neidhart, A-C.
Redureau, E.
Chiappa, A-M.
Bigot, F.
Bedossa, A.
Amrane, K.
Jeandeau, S.
Dujon, C.
Bugnet, A-S.
Bonnefoy, P.
Alizon, C.
Meyer, N.
Couraud, S.
Cortot, A.
Letierce, A.
Debieuvre, D.
509P COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study
title 509P COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study
title_full 509P COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study
title_fullStr 509P COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study
title_full_unstemmed 509P COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study
title_short 509P COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study
title_sort 509p covid-19 disease among lung cancer (lc) patients: data from a real-life prospective multicentric study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472519/
http://dx.doi.org/10.1016/j.annonc.2022.07.637
work_keys_str_mv AT moliniero 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT falcherol 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT monneti 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT decroisettec 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT neidhartac 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT redureaue 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT chiappaam 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT bigotf 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT bedossaa 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT amranek 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT jeandeaus 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT dujonc 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT bugnetas 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT bonnefoyp 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT alizonc 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT meyern 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT courauds 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT cortota 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT letiercea 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy
AT debieuvred 509pcovid19diseaseamonglungcancerlcpatientsdatafromareallifeprospectivemulticentricstudy